Trending News Today: FDA Proposes Restricting 3 Substances from Bulk Drug Compounding
Top news of the day from across the health care landscape
On Monday, officials with the FDA proposed excluding 3 substances from a list of ingredients that could be used for compounding medications in bulk,
Weight loss drug Belviq was deemed successful in a long-term heart safety study, demonstrating no increased cardiovascular risks associated with the product, the
The FDA rejected Akcea Therapeutics’ application to market Waylivra, also known as volanesorsen, its drug for familial chylomicronemia syndrome,
Newsletter
Stay informed on drug updates, treatment guidelines, and pharmacy practice trends—subscribe to Pharmacy Times for weekly clinical insights.
Related Articles
- Effectively Managing Immunizations in the Long-Term Care Setting
September 18th 2025
- Creating a Culture of Quality in Fast-Melt Tablet Development
September 18th 2025
- Advise Patients About Self-Care Measures to Treat Mild to Moderate GI Issues
September 18th 2025